#United States #New York #Gross Law Firm #Cardlytics #CDLX

Call for Action: Cardlytics Shareholder Lawsuit Deadline

In a recent announcement, The Gross Law Firm is urging shareholders of Cardlytics, Inc. (NASDAQ: CDLX) who acquired shares during specific periods to take immediate action ahead of the impending deadline in a class action lawsuit. Shareholders who bought shares of CDLX from March 14, 2024, to August 7, 2024, are encouraged to register with the firm to secure a potential lead plaintiff position. This registration does not come with any obligations to participate in recovery, allowing all shareholders to consider their options safely.

Understanding the Allegations

The lawsuit revolves around allegations that during the specified class period, Cardlytics issued materially false statements and failed to disclose crucial information regarding its business operations and forecasts. Notably, it is claimed that increasing consumer engagement resulted in heightened consumer incentives, which, unexpectedly, did not align with the company's ability to raise billings proportionately. Consequently, there were growing risks that revenue growth could stagnate or decline.

Moreover, changes to their Ads Decision Engine, intended to boost consumer engagement, allegedly caused discrepancies in budget delivery and billing estimates, leading to misleading statements about the company's operational health and future prospects. These developments, if proven, suggest that investors may have been misled about the reliability of Cardlytics’ performance metrics.

Time is of the Essence

The firm is emphasizing the urgency behind registering for this class action, with the lead plaintiff deadline set for March 25, 2025. Shareholders are strongly advised not to procrastinate and to register their information promptly to stay updated on the case's progression. By signing up, they will also gain access to monitoring tools that will provide real-time updates throughout the legal proceedings.

Every investor deserves the opportunity to recover losses incurred due to alleged deceitful practices that inflate stock values unreasonably. Therefore, the Gross Law Firm remains committed to supporting investors who may have suffered as a result of misleading corporate behavior.

Why Choose The Gross Law Firm?

As a nationally recognized class action law firm, The Gross Law Firm advocates for investors' rights impacted by false or misleading information. Their dedication extends to ensuring that companies uphold responsible business practices and engage in ethical corporate duties. The firm actively seeks recovery for losses stemming from artificially inflated stock values due to misrepresentation of information.

If you qualify as a shareholder who purchased shares of Cardlytics within the designated timeframe, remember to act swiftly and register. Your participation could be vital in holding the company accountable and may pave the way for potential financial recovery.

For further details and to register, shareholders can visit the Gross Law Firm’s dedicated page: Registration Link.

Contact Information

For any inquiries, shareholders can contact The Gross Law Firm directly:
Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
Email: info@securitiesclasslaw.com
Phone: (646) 453-8903

The time to act is now; ensure your voice is heard and your rights as an investor are protected before the crucial deadline passes.